Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Helicobacter pylori 30S ribosomal subunit is a fundamental component of the bacterial protein synthesis machinery, serving as the primary site for mRNA decoding and translation initiation (UniProt, 2023). It is composed of the 16S ribosomal RNA (rRNA) and approximately 21 ribosomal proteins, forming a complex that ensures the fidelity of genetic translation (PubMed: 31503231). This subunit is a major pharmacological target for antibiotics such as tetracyclines, which bind to the 16S rRNA to block the entry of aminoacyl-tRNA into the A-site, thereby halting protein production (PubChem, 2024). H. pylori infections are a primary cause of chronic gastritis and peptic ulcers, and they are strongly associated with the development of gastric adenocarcinoma and MALT lymphoma (StatPearls, 2023). The clinical efficacy of drugs targeting the 30S subunit is increasingly threatened by the emergence of resistance, often mediated by specific point mutations in the 16S rRNA gene (PubMed: 15933035). Consequently, the 30S subunit remains a focal point for structural biology and drug discovery efforts aimed at overcoming antibiotic-resistant strains of H. pylori.
Inhibition of bacterial protein synthesis by binding to the 16S rRNA of the 30S ribosomal subunit, which prevents the association of aminoacyl-tRNA with the ribosomal A-site.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori 30S ribosomal subunit (30S subunit).